Journal of Medicinal Chemistry · 2007 · 98 citations · 9 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyCyclic Nucleotide SignalingLigand BindingLigand-based DesignPotency OptimizationReceptor PharmacologyMurine ModelsNucleoside Analog SynthesisNucleoside AnalogsNucleoside ModificationNucleotide AnalogsPurine AnalogsPurine AnaloguesPurine Chemistry
Truncated D-4'-thioadenosine derivatives lacking the 4'-hydroxymethylene moiety were synthesized starting from D-mannose, using cyclization to the 4-thiosugar and one-step conversion of the diol to the acetate as key steps. At the human A3 adenosine receptor (AR), N6-substituted purine analogues bound potently and selectively and acted as antagonists in a cyclic AMP functional assay. An N6-(3-chlorobenzyl)purine analogue 9b displayed a Ki value of 1.66 nM at the human A3 AR. Thus, truncated D-4'-thioadenosine is an excellent template for the design of novel A3 AR antagonists to act at both human and murine species.
9
A3 Adenosine Receptor Activation in Melanoma Cells
Lea Madi, Sara Bar‐Yehuda, Faina Barer et al. · Journal of Biological Chemistry · 2003 · 100 citations · Full text
Medicine, Oncology, Pharmacology +17
Lak Shin Jeong, Hyuk Woo Lee, Kenneth A. Jacobson et al. · Journal of Medicinal Chemistry · 2005 · 71 citations · Full text